New site trumprx.gov unveiled to offer discounted prescription drugs

Unidentified Event · February 6, 2026

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Speakers at an event announced trumprx.gov, saying the site will offer dramatic discounts on dozens of commonly used prescription drugs; a military spouse said lower drug costs could help make IVF affordable for her family.

Speakers at an event unveiled trumprx.gov, a website they said will make dozens of commonly used prescription drugs available at significant discounts to U.S. consumers.

Organizers framed the launch as a major step to address what they described as long-running disparities in drug prices between the United States and other countries. "Americans have long been paying the highest drug prices anywhere in the world, while other countries often paid pennies on the dollar for the exact same drugs," said Unidentified Speaker 1.

The announcement named the website trumprx.gov as the online platform that will host the discounted offerings. "Dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers throughout a new website," Unidentified Speaker 1 said.

A military spouse who spoke at the event said the policy could have direct effects on families facing high medical costs. "I'm a military spouse, and my husband and I have been navigating infertility and IVF for 5 years, a journey that has included profound loss," said Unidentified Speaker 2. She added that "the president's leadership on price transparency and on reducing the cost of medications has a real and immediate impact," saying those efforts "help ensure that IVF remains within reach for families who are doing everything that they can to build a future." She concluded by thanking leadership for that commitment.

Event remarks focused on the potential for lower drug prices to reduce out-of-pocket costs for treatments and for related services such as fertility care. The speakers did not provide specific rollout dates, detailed lists of drugs included, pricing formulas or information about enrollment and eligibility during the remarks.

Next steps and implementation details—such as what drugs are included, how discounts will be calculated, whether insurers will adjust copays, or how the site will be administered—were not specified at the event.